Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Portland-Vancouver-Beaverton, OR-WA MSA — September 2026
Portland's job market is shrinking — life sciences talent isn't getting cheaper.
Portland shed 32,600 payroll jobs over the past year and unemployment sits at 4.9%, yet Regulatory Affairs, Biostatistics, and Clinical Data Manager pay all climbed significantly, underscoring how disconnected specialized life sciences hiring is from the broader metro slowdown.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Portland metro unemployment: 4.9% — vs 5.1% Oregon statewide, 4.1% national
- Metro payroll job losses: -32,600 — March 2025-March 2026, 2nd-worst U.S. metro
- Regulatory Affairs Specialist pay: $110,343 — Up significantly locally vs stable nationally
- Lab/R&D vacancy rate: 23.2% — Top 13 U.S. life sciences markets, Q1 2026
Key takeaways
Regulatory and data roles are pulling away from the pack.
Regulatory Affairs Specialist, Clinical Data Manager, and Biostatistician advertised pay all moved up significantly in Portland this month, well outpacing the metro's otherwise soft labor market. Scarcity in these functions, not general wage inflation, is driving the premium — a signal to benchmark these roles against current demand rather than last year's bands.
Clinical Research Associate pay is diverging from the national trend.
Metro CRA pay moved down moderately to $77,720 even as national CRA pay climbed significantly to $90,956, an unusual local softening that may reflect Portland's broader professional-services contraction bleeding into clinical operations hiring. Leaders recruiting CRAs regionally may find more room to negotiate than the national data would suggest.
Metro-level softness doesn't extend to specialized science talent.
Portland's second-worst-in-the-nation payroll job losses and 4.9% unemployment mask a genuinely tight market for regulatory, biostatistics, and lab talent. Headcount planning should separate general labor market slack from the credential-driven scarcity still shaping R&D, clinical, and quality hiring.
Cross-company hiring coordination signals the poaching problem is structural.
Oregon Life Sciences Association's move to let member companies share hiring plans — normally competitively guarded information — reflects how acute specialized talent competition has become. Smaller Oregon biotechs weighing in-house regulatory builds against CDMO/CRO reliance should treat this coordination as a read on how tight the local bench really is.
Median advertised pay by role — Portland-Vancouver-Beaverton, OR-WA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $147,797 | $148,237 | $148,238 | Stable | $131,354 |
| Clinical Research Associate | $63,128 | $77,720 | $95,459 | Moderate decline | $90,956 |
| Lab Technician | $45,169 | $59,228 | $62,343 | Moderate increase | $47,402 |
| Regulatory Affairs Specialist * | $89,000 | $110,343 | $118,621 | Significant increase | $104,000 |
| Clinical Data Manager * | $124,704 | $142,800 | $145,083 | Significant increase | $123,031 |
| Biostatistician * | $109,447 | $168,864 | $170,803 | Significant increase | $133,322 |
| Validation Engineer | $93,496 | $111,156 | $113,942 | Moderate decline | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Portland metro employment continues to soften against the national grain — the region shed 32,600 nonfarm payroll jobs between March 2025 and March 2026, the second-worst metro decline in the country, while unemployment holds at 4.9% even as Washington County's tech- and manufacturing-heavy base sits at a tighter 3.7%. Against that backdrop, life sciences hiring remains an outlier: regional lab and R&D vacancy pressure, GLP-1-driven manufacturing demand, and Oregon Life Sciences Association coordination on workforce planning are keeping specialized scientific and regulatory roles competitive even as broader metro labor demand contracts.
What it means
Portland's uneven labor market — soft overall but tight for credentialed scientific talent — means Life Sci leaders can expect easier sourcing for general operational roles while continuing to face real scarcity in regulatory affairs, biostatistics, and clinical data management. Advertised pay for Regulatory Affairs Specialist, Clinical Data Manager, and Biostatistician roles are all up significantly locally, a signal that build-vs-outsource tradeoffs for these functions are shifting toward CRO/CDMO reliance where internal hiring timelines can't keep pace. Consider reviewing compensation bands for regulatory and biostatistics roles against the metro's upward trend lines before committing to in-house headcount expansion in these functions.
Looking ahead
Worth watching: Oregon's September payroll data releases October 14 and will clarify whether the metro's job losses are stabilizing or deepening. A continued decline in professional and business services could eventually loosen clinical operations and regulatory support hiring.
Emerging pressure point: National September layoff activity in biopharma (BioMarin, Bristol Myers) hasn't yet shown up meaningfully in Oregon WARN filings, but 64% of biopharma organizations report active recruiting alongside restructuring elsewhere. Watch whether displaced regulatory or CMC talent from national cuts enters the Portland candidate pool.
Potential inflection point: Intel's $36 billion Hillsboro upgrade could tighten competition for automation and process engineering talent that overlaps with life sciences manufacturing and bioprocess roles. Validation Engineer pay already moved down moderately this month — worth tracking whether cross-industry competition reverses that trend.
Early indicator: Lab/R&D vacancy reached 23.2% across top U.S. life sciences markets in Q1 2026; if Portland tracks that national rate, unfilled R&D seats could pressure headcount plans through year-end. Monitor whether Oregon Life Sciences Association's hiring-plan sharing initiative begins showing measurable retention effects.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.